Targeting Mycobacterium tuberculosis iron-scavenging tools: A recent update on siderophores inhibitors

G Kumar, PA Adhikrao - RSC Medicinal Chemistry, 2023 - pubs.rsc.org
Among the various bacterial infections, tuberculosis (TB) remains a life-threatening
infectious disease responsible as the most significant cause of mortality and morbidity …

Small molecules with structural similarities to siderophores as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis

KL Stirrett, JA Ferreras, V Jayaprakash… - Bioorganic & medicinal …, 2008 - Elsevier
Drugs inhibiting the iron scarcity-induced, siderophore-mediated iron-scavenging systems of
Mycobacterium tuberculosis (Mtb) and Yersinia pestis (Yp) may provide new therapeutic …

Iron regulation in tuberculosis research: promise and challenges

AK Sharma, R Naithani, V Kumar… - Current medicinal …, 2011 - ingentaconnect.com
Tuberculosis is a major global health challenge and is far from being controlled.
Development of resistance to currently available drugs due to the successful adaptation of …

Iron acquisition pathways as targets for antitubercular drugs

F Meneghetti, S Villa, A Gelain… - Current Medicinal …, 2016 - ingentaconnect.com
Tuberculosis nowadays ranks as the second leading cause of death from an infectious
disease worldwide. In the last twenty years, this disease has again started to spread mainly …

[HTML][HTML] Advances in mycobacterium siderophore-based drug discovery

J He, J Xie - Acta Pharmaceutica Sinica B, 2011 - Elsevier
Tuberculosis remains a public health threat of global proportions. Iron is a scarce resource
indispensable to both host and pathogen during infection with Mycobacterium tuberculosis …

Targeting iron acquisition by Mycobacterium tuberculosis

RR Monfeli, C Beeson - Infectious Disorders-Drug Targets …, 2007 - ingentaconnect.com
Tuberculosis (TB) caused by the pathogen Mycobacterium tuberculosis continues to be a
major worldwide health problem. Lack of compliance to the complex, multi-drug therapy …

Drug targeting of heme proteins in Mycobacterium tuberculosis

KJ McLean, AW Munro - Drug Discovery Today, 2017 - Elsevier
Highlights•Mycobacterium tuberculosis causes more deaths than any other infectious
disease.•Heme-binding enzymes are crucial for M. tuberculosis survival in its human …

Integrated target‐based and phenotypic screening approaches for the identification of anti‐tubercular agents that bind to the mycobacterial adenylating enzyme MbtA

L Ferguson, G Wells, S Bhakta, J Johnson… - …, 2019 - Wiley Online Library
Iron is essential for the pathogenicity and virulence of Mycobacterium tuberculosis, which
synthesises salicyl‐capped siderophores (mycobactins) to acquire this element from the …

Modulating iron for metabolic support of TB host defense

JJ Phelan, SA Basdeo, SC Tazoll, S McGivern… - Frontiers in …, 2018 - frontiersin.org
Tuberculosis (TB) is the world's biggest infectious disease killer. The increasing prevalence
of multidrug-resistant and extensively drug-resistant TB demonstrates that current treatments …

Iron Acquisition in Mycobacterium tuberculosis

A Chao, PJ Sieminski, CP Owens… - Chemical …, 2018 - ACS Publications
The highly contagious disease tuberculosis (TB) is caused by the bacterium Mycobacterium
tuberculosis (Mtb), which has been evolving drug resistance at an alarming rate. Like all …